Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep

People with drug-resistant focal epilepsy frequently wake up during the night, but it has been unclear whether those awakenings are caused by the epileptic activity itself or whether underlying sleep instability independently drives both problems. This study from the Hospices Civils de Lyon uses a rare, high-resolution combination of stereoelectroencephalography (SEEG) — electrodes implanted deep in the brain for pre-surgical mapping — recorded simultaneously with full polysomnography (PSG), which tracks sleep stages, muscle tone, eye movements, and breathing. The investigators aim to determine whether nocturnal seizures and interictal epileptiform discharges (IEDs, the brief electrical spikes seen between seizures) directly trigger arousals and awakenings, or whether the timing relationship is coincidental. A clinically important secondary question is whether these nocturnal disruptions affect the mental content patients experience during sleep — dreams, nightmares, or the absence of any recalled experience. Because nocturnal seizures are often dismissed as less disabling than daytime events, demonstrating a direct causal link to sleep fragmentation could change how clinicians weigh treatment decisions. The study is currently recruiting and has a projected completion date of May 2026. If causality is confirmed, it would reframe nocturnal epileptic activity from a passive correlate of poor sleep to an active driver of sleep disruption with real consequences for wellbeing and cognition.

• Prior work by the same group using simultaneous SEEG-PSG showed that sleep fragmentation in focal drug-resistant epilepsy is associated with both ictal (seizure) and interictal epileptic activity — this trial is designed to establish the direction of causality, so primary findings are not yet available.
• The investigators previously documented increased interictal epileptiform discharge (IED) rates immediately before and during arousals, raising the hypothesis that IEDs actively precipitate awakenings rather than merely co-occurring with them.
• A novel secondary outcome is the characterisation of mental content during sleep (dreams, nightmares, absence of recall) adjacent to epileptic events, an aspect of patient experience that has rarely been systematically studied in this population.

This is a prospective observational clinical study (ClinicalTrials.gov NCT07605858) conducted at Hospices Civils de Lyon in adult patients with drug-resistant focal epilepsy who are already undergoing invasive SEEG monitoring as part of standard pre-surgical evaluation. Simultaneous full polysomnography is recorded alongside the SEEG to allow precise temporal alignment of epileptic events with sleep-stage transitions, arousals, and awakenings. Patients are also systematically queried about sleep mentation to capture mental content associated with epileptic events occurring across different sleep stages. Sample size, exact follow-up duration per participant, and statistical analysis plan are not specified in the available abstract; the study is listed as recruiting with a status update through May 2026.

Because SEEG is only placed in patients with drug-resistant epilepsy being evaluated for surgery, the findings will not be generalisable to well-controlled or newly diagnosed epilepsy, nor to the general population with sleep disturbances. The observational design, while capturing naturalistic epileptic activity, cannot experimentally suppress IEDs to test causality in the strictest sense — causal inference will depend on temporal analyses and statistical modelling rather than intervention. The study does not appear to include a non-epileptic control group recorded with PSG, which limits comparisons of baseline sleep architecture. A future randomised or interventional trial targeting IED suppression (e.g., via responsive neurostimulation) and measuring sleep continuity as an outcome would be the logical next step to confirm causality and clinical relevance.

This trial sits at the intersection of invasive neurophysiology and sleep biology, extending the corpus's exploration of how neural circuit dynamics shape sleep architecture. It parallels [§121], which investigates low-dimensional brainstem population dynamics gating REM sleep, in that both studies seek neural-circuit-level mechanisms underlying sleep-stage transitions — but this trial operates at the clinical macro-level using human SEEG rather than animal circuit models. It also parallels [§133], which examines how sleep disruption interacts with central oxidative stress and circadian signalling, since both recognise sleep fragmentation as both a consequence and a potential driver of pathological brain states. The study extends the question raised implicitly by [§33] (time-restricted eating for Alzheimer's disease), which targets sleep-wake rhythm disruption in a neurological population, by asking whether the source of that disruption in epilepsy is endogenous electrical activity rather than circadian misalignment. Taken together, these articles collectively build a picture of sleep as an active, mechanistically complex state whose disruption in neurological disease requires condition-specific interrogation rather than a one-size-fits-all framework.

• Low-dimensional population dynamics in the brainstem gate REM sleep
  Investigates the brainstem circuit dynamics that gate REM sleep transitions, providing a complementary mechanistic framework for understanding why epileptic discharges at specific sleep stages may be particularly disruptive to sleep architecture.
• Sleep, Light, Circadian, Central Oxidative Stress
  Examines how sleep disruption interacts with circadian and oxidative-stress pathways in brain disease, offering a broader biological context for the downstream consequences of the sleep fragmentation this epilepsy trial aims to characterise.
• TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
  Trials a chronobiological intervention (time-restricted eating) to stabilise sleep-wake rhythms in Alzheimer's disease, illustrating how sleep disruption in a different neurological population has been translated into a treatment target — a pathway this epilepsy study could inform.
• Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
  Assesses neurocognitive and health consequences of sleep disruption in elderly veterans with comorbid COPD and sleep apnea, providing a useful comparator for how objectively measured sleep fragmentation — regardless of aetiology — maps onto cognitive and functional outcomes.
• Enhancing Slow Wave Sleep in Depression
  Examines slow-wave sleep enhancement in depression, a condition with known sleep-architecture abnormalities, making it a relevant parallel for evaluating whether targeted manipulation of sleep microstructure can reverse neuropsychiatric consequences of chronic sleep disruption.